Disclosures

Editorial Board Member: Dr Andrew Gennery

Watson Reader/Honorary Consultant in Paediatric Immunology & Haematopoeitic Stem Cell Transplantation. Newcastle University and Great North Children’s Hospital, Newcastle upon Tyne, UK.

Disclosures: Dr Gennery has delivered lectures as part of an ‘in- house’ education staff to GSK Staff – Haematopoietic Stem Cell Transplantation for Primary Immunodeficiencies

Editorial Board member: Dr Robbert Bredius

MD PhD, Paediatric Immunologist – Infectious Disease – Stem Cell Transplant Dr. Department of Paediatrics, Immunology section, Hematology and Stem Cell Transplantation, Leiden University Medical Centre, The Netherlands.

Disclosures: Dr Bredius has delivered industry symposia presentations funded by GSK

Editorial Board member: Dr Fabio Candotti

MD PhD, Pediatrics, Pediatric Allergy and Immunology
Associate Professor of Medicine and Head Physician, Division of Immunology and Allergy
Director, Vaccine and Immunotherapy Center, University Hospital of Lausanne, Switzerland

Disclosures: Dr Candotti has no conflicts of interest to declare.

Expert Interviewee: Professor Marina Cavazzana

Head of the Biotherapy Department, Necker Chidren’s Hospital, Assistance Publique-Hôpitaux de Paris, France

Disclosures: Professor Cavazzana stated that she has no relationships to disclose

 

Share This: